It's an exciting time in the evolution of the understanding and management of multiple sclerosis. In this issue of ReFlections, Dr. Heather Lund, Regional Chief Medical Officer, Asia, offers an extensive and detailed piece providing much of the latest research ... Read More

As the world continues to battle COVID-19 and emerging variants of the SARS-CoV-2 virus, the life and health insurance industry finds itself both reviewing lessons learned and preparing for what will happen next. (Re)insurers’ ability to estimate COVID-19’s current a...

Read More

The long-term impacts of the COVID-19 pandemic on product innovation and development strategies are yet to be determined, but RGA's Dan Lyons suggests that a few major changes may remain and even become more common.
Read More

Review reactive thrombocytosis, explore multiple sclerosis, and understand pharmacogenomics in this issue.


Read More

Retirees need the reassurance a steady stream of income provides, argues RGA's Diana Bosworth. She tours an increasingly vibrant product development landscape oriented around encouraging financial wellness in retirement.  Read More

Research shows that timely, efficient, accurate, and fair claims settlements can strengthen the customer relationship in profound ways. On the other hand, underinvestment in claims can result in real reputational damage. RGA makes the case for claims innovation.  Read More

Curious about RGA's medical insights?  Contact us to learn m...

Read More

China is committed to making quality healthcare affordable and accessible to its residents, however it faces substantial challenges. RGA's Dipali Jawalkar provides an overview of China's health infrastructure, technology's impact on insurance product innovation,...

Read More

How will the COVID-19 pandemic impact life and health insurance distribution and sales in the long term? Peter Rodes and Eva Goldstein of RGAX, the transformation engine of RGA, discuss the key drivers of insurance's accelerated convergence. Read More

Curious about RGA’s global survey results? 

Read More

Aducanumab (Aduhelm^TM), a new drug designed to treat Alzheimer's disease was approved by the FDA on June 7, 2021. RGA's Dr. Dave Rengachary discusses what this means for insurance, as well as the controversies around it.

Read More

Read More

Trey Reynolds, Executive Vice President, Strategy & New Business Development, MIB Group, Inc., presents on the jumbo solution and is joined by other leading voices in the fraud-fighting community at the RGA Fraud Conference.

Read More

Today, a diagnosis of cancer requires a traditional biopsy consisting of direct tissue sampling and analysis, but liquid biopsies are changing the game. Read More

RGA's Hilary Henly provides an overview of natural and vaccine-induced COVID-19 immunity, how long immunity is likely to last, whether booster shots will be needed, and more.

Evidence to date suggests that individuals previously infected with SARS-CoV-2 who are... Read More

Multi-state models, or MSMs, can help actuaries better characterize individuals as they progress through disease states. RGA's Kishan Bakrania, Chris Falkous, and Richard Russell provide a clear-eyed introduction to this form of modeling and share use cases...

Read More

RGA is a proud member of the Coalition Against Insurance Fraud, America’s only anti-fraud alliance speaking for consumers, insurance companies, government agencies, and others. We invit... Read More

As part of an ongoing series in On the Risk, RGA's Taylor Pickett, an actuary, and Catie Muccigrosso, an underwriter, examine the relationship between their professions and underscore the crucial role underwriters play in the development and implementation o...

Read More

Up to 70% of breast cancer patients prescribed chemotherapy after their surgeries might not need it. But how can clinicians make that decision, and insurers determine whether to cover the determining tests?  Read More

Adjudication of overseas claims may be challenging, but being aware of red flags and having an effective claims strategy and processing framework will help ensure the validity of claims and avoid fraudulent activity. 
Read More